SmartTarget

The SmartTarget device is a software-based system designed to enhance visualization for image-guided prostate interventions by fusing real-time transrectal ultrasound (TRUS) images with pre-acquired 3D diagnostic scans like MRI. It utilizes 3D TRUS reconstruction, image registration, and mechanical probe tracking via position encoders to allow clinicians to plan and accurately guide instruments to targeted regions within the prostate.

SmartTarget is a software-based accessory designed for physicians performing image-guided interventional and diagnostic procedures involving the prostate gland. Its primary purpose is to enhance visualization of transrectal ultrasound (TRUS) images by fusing them with pre-procedural 3D diagnostic images like MRI or CT. The system facilitates computer-assisted surgical planning by allowing users to define target regions within the prostate, segment medical images, and reconstruct 3D TRUS volumes from 2D video frames. It provides comprehensive 2D and 3D image visualization tools, including multi-planar views, image annotation, and the ability to record the locations of inserted instruments, thereby aiding in guiding these instruments to specific areas of interest within the prostate. The SmartTarget software operates on a PC platform using the Windows operating system and supports DICOM image import. Its methodology involves capturing TRUS video, reconstructing it into a 3D volume, and then registering this volume with existing 3D diagnostic scans (e.g., MRI). The system employs position encoders attached to a third-party mechanical TRUS probe stepper device to determine the probe's 3D position and orientation, a technique differing from some predicates that use electromagnetic tracking. Graphical overlays representing target regions are superimposed onto the TRUS images. Non-clinical bench testing using phantoms demonstrated an image alignment error of 2.0mm between ultrasound and MRI volumes and an overall needle-tip placement error of 2.9mm, which are deemed acceptable for its intended clinical applications such as biopsies, thermal ablations, and brachytherapy.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the 2.9mm needle-tip placement error observed in phantom studies translate to clinical accuracy across various prostate sizes and anatomical variations?; What is the typical learning curve for clinicians to become proficient in using SmartTarget for image fusion and target definition, especially those accustomed to electromagnetic tracking systems?; Given that SmartTarget uses mechanical position encoders, how susceptible is the system's accuracy to potential mechanical drift, calibration variations, or interference in a busy clinical environment compared to electromagnetic systems?; Since SmartTarget does not support transrectal instrument insertion, what are the specific procedural or anatomical contraindications that led to this limitation, and how does it impact its utility for the full spectrum of prostate interventions?; What specific algorithms are used for the elastic registration component, and how has their robustness been validated against prostate deformation that occurs during TRUS-guided procedures?